Leto Laboratories
Latest round
- Series C
Last raised
- Jul 2025
Total raised
- $30M
Investors
- 13
About Leto Laboratories
Established in 2014 and based in Beijing, China, Leto Laboratories operates as a protein technology and drug developer that providesprotein products, drugs and protein technology platform. The company headquartered in Beijing and its laboratories passed ISO9001:2008 quality system certification. It cooperates with Hansen Pharmaceutical, Tonghua Dongbao and Junshi Biological. Wei Zhang, the CEO and founder of the company, and he once served as the senior research fellow at a leading UK oncology research center and Novo Nordisk. The company provides protein products, drugs and protein technology platform. It develops more than 10 drug discovery platforms, including computer-aided drug design platform, high-throughput protein preparation platform and high-throughput protein screening platform. Its products include refolding, cytokine and peptide drugs. Cytokine can apply in oncology treatment, infection and autoimmune diseases fields.
Who invested in Leto Laboratories
13 investors across 6 rounds
See all investors in Leto Laboratories
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Questions about Leto Laboratories
Who invested in Leto Laboratories?
Leto Laboratories has 13 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Leto Laboratories raised?
Leto Laboratories has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Leto Laboratories last raise money?
Leto Laboratories's most recent round on record is a Series C, in Jul 2025.
What does Leto Laboratories do?
Established in 2014 and based in Beijing, China, Leto Laboratories operates as a protein technology and drug developer that providesprotein products, drugs and protein technology platform.
Where is Leto Laboratories headquartered?
Leto Laboratories is headquartered in Beijing, China.
Which VCs invest in companies like Leto Laboratories?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Leto Laboratories's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Leto Laboratories? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.